← All medicines
Xenleta 150 mg concentrate for solution for infusion
Licence EU/1/20/1457/001 · Unknown
- Licence holder
- Nabriva Therapeutics Ireland Designated Activity Company (all products →)
- Active substance
- Lefamulin
- Dosage form
- Concentrate and solvent for solution for infusion
- Routes of administration
- Intravenous use, Oral use
- ATC codes
- J01XX, J01XX12
- First authorised
- 27/07/2020
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.